Crossmark

Assessing the Risk of Decrease in Kidney Function in Patients Prescribed Direct-Acting Antivirals for Hepatitis C Utilizing the MID-NET® Medical Information Database Network in Japan

Crossref DOI link: https://doi.org/10.1007/s43441-022-00400-5

Published Online: 2022-04-18

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hasegawa, Tomoaki https://orcid.org/0000-0002-8602-8295
Sawada, Sono

Ishiguro, Chieko https://orcid.org/0000-0002-1302-9430
Ando, Takashi https://orcid.org/0000-0002-0654-5656
Kobayashi, Kanae

Komiyama, Noriyuki

Iguchi, Toyotaka

Nonaka, Takahiro https://orcid.org/0000-0003-1320-6190
Uyama, Yoshiaki https://orcid.org/0000-0002-0430-9887
License Information

Text and Data Mining valid from 2022-04-18

Version of Record valid from 2022-04-18
More Information

Article History

Received: 21 October 2021

Accepted: 18 March 2022

First Online: 18 April 2022

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below